Non-Small Cell Lung Cancer: Management of Patients with Resectable Disease
Many patients with stages I to IIIA NSCLC are eligible for surgery followed by adjuvant therapy. Multidisciplinary evaluation is recommended to decide whether patients with stages I to IIIA NSCLC have resectable disease and to determine the most appropriate surgical procedure. The NCCN Guidelines now recommend biomarker testing for EGFR mutations in patients with completely resected stages IB to IIIA NSCLC to determine whether they are eligible for certain adjuvant targeted therapy. Previously, the NCCN Guidelines only recommended biomarker testing for eligible patients with advanced NSCLC.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Targeted Therapy for Patients with Metastatic Non-Small Cell Lung Cancer
The rapid pace of updates to the NCCN Guidelines for NSCLC makes it challenging for health care providers to stay informed about current recommendations, including how to assess for and manage side effects with the newer agents.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates to Management of Patients with Multiple Myeloma
To navigate through the complex treatment landscape, physicians and other oncology care providers must understand the evolving therapeutic options and guidelines for administration of the available therapies in the context of the patient's therapeutic and disease history. The increasing complexity of myeloma treatment warrants rigorous efforts to provide adequate supportive care and preserve the quality of life of patients.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenging Case Review: Non-Small Cell Lung Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with non-small cell lung cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
State Legislation Addressing Specialty Pharmacy Policy
Payer/pharmacy benefit manager (PBM) intrusion into the patient care continuum is a major risk to quality. Treatment delays as a result of white-bagging policies are increasing in frequency. PBM/payer restrictions have increased and are a potential threat to high-quality guideline concordant care as they could steer patients to less efficacious treatments that cost the health plans less money. As the federal government has been slow to act, having an understanding for how state legislatures have begun to address these issues can help those involved in the care of patients with cancer to work within their cancer community to best address these issues at a local level.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Approaches for the Treatment of Patients with Anal Carcinoma
Anal cancer is rare but increasing in incidence, making education on how to treat advanced or metastatic disease important for clinicians. There have recently been significant, practice-changing developments in systemic therapy options for advanced anal cancer based on clinical trial results and pending FDA approvals, making this a timely topic for discussion.
Category
  • Anal Carcinoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Strategies and Initiatives to Improve New Patient Access to Cancer Care
Many cancer centers operate at or close to full capacity and have difficulty scheduling patient appointments in a timely manner. Delayed patient appointments may directly impact patient outcomes when a patient is unable to seek treatment. A delayed appointment may also cause additional distress for patients who are anxious to schedule treatment.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Plenary Session – The Patient Journey: Cancer Survivor Care
Unfortunately, many cancer survivors report unmet psychosocial needs; therefore, it is critical to educate clinicians who work with cancer survivors on the prevalence of, risk factors for, and optimal management of anxiety, depression, trauma, and distress.
Category
  • Distress Management
  • Survivorship
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates in Oncology: Oral Presentations from the NCCN Poster Sessions
The seven top-rated abstracts from the NCCN 2022 Annual Conference Poster Session are showcased here.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Pancreatic Adenocarcinoma: Emerging Systemic Therapy Options
Systemic therapy is an area of active research for pancreatic cancer. Given the increase in pancreatic cancer mortality rates, it is important for clinicians to stay up-to-date with the most recent trial data and existing challenges in systemic therapy development for pancreatic cancer.
Category
  • Pancreatic Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages